Yanqi Ye
Impact in
- Pharmaceutical Science top 0.05%
- Advancements in Transdermal Drug Delivery
- Advanced Drug Delivery Systems
- Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Advancements in Transdermal Drug Delivery 15
- Advanced Drug Delivery Systems 5
-
- Nanoparticle-Based Drug Delivery 5
- Journals
- Advanced Materials (6 papers)ACS Nano (5 papers)Nature Biomedical Engineering (3 papers)Frontiers in Immunology (2 papers)Nano Research (2 papers)
- Partner nations
- United StatesChinaAustralia
In The Last Decade
Yanqi Ye
46 papers receiving 7.2k citations
Hit Papers
Peers
Comparison fields: 5 of 141
- Pharmaceutical Science 2.0k
- Biomaterials 1.6k
- Immunology 1.8k
- Dermatology 715
- Biomedical Engineering 3.1k
Countries citing papers authored by Yanqi Ye
This map shows the geographic impact of Yanqi Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanqi Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanqi Ye more than expected).
Fields of papers citing papers by Yanqi Ye
This network shows the impact of papers produced by Yanqi Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanqi Ye. The network helps show where Yanqi Ye may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yanqi Ye, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 1 | |
| 3 | Smart nanoparticles for cancer therapy Hit paper breakdown → | 2023 | 540 |
| 4 | 2023 | 0 | |
| 5 | 2022 | 45 | |
| 6 | 2022 | 69 | |
| 7 | 2021 | 24 | |
| 8 | 2021 | 18 | |
| 9 | 2020 | 0 | |
| 10 | 2020 | 14 | |
| 11 | Glucose-responsive insulin patch for the regulation of blood glucose in mice and minipigs Hit paper breakdown → | 2020 | 491 |
| 12 | 2019 | 138 | |
| 13 | 2019 | 47 | |
| 14 | 2018 | 249 | |
| 15 | 2018 | 2 | |
| 16 | 2018 | 276 | |
| 17 | 2018 | 262 | |
| 18 | 2017 | 61 | |
| 19 | 2016 | 41 | |
| 20 | 2016 | 214 |
About Yanqi Ye
Yanqi Ye is a scholar working on Pharmaceutical Science, Biomaterials, Immunology, Biophysics and Molecular Biology, having authored 49 papers that have together received 7.2k indexed citations. Recurring topics across this work include Advancements in Transdermal Drug Delivery (15 papers), Lipid Membrane Structure and Behavior (10 papers), Immunotherapy and Immune Responses (9 papers), Nanoplatforms for cancer theranostics (8 papers), Nanoparticle-Based Drug Delivery (5 papers), Advanced Drug Delivery Systems (5 papers), CAR-T cell therapy research (5 papers) and Diabetes Management and Research (4 papers). The work is most often cited by research in Pharmaceutical Science (2.0k citations), Biomaterials (1.6k citations), Immunology (1.8k citations), Dermatology (715 citations) and Biomedical Engineering (3.1k citations). Yanqi Ye has collaborated with scholars based in United States, China and Australia. Frequent co-authors include Zhen Gu, Chao Wang, Quanyin Hu, Jicheng Yu, Wujin Sun, Jinqiang Wang, John B. Buse, Gabrielle Hochu, Hunter N. Bomba and Hasan Sadeghifar. Their work appears in journals such as Advanced Materials, ACS Nano, Nature Biomedical Engineering, Frontiers in Immunology and Nano Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.